Dr Alan Nafiiev
Dr Alan Nafiiev is the CEO and Founder of Receptor.AI, where he develops AI-driven infrastructure for drug discovery. With a PhD in computer science, his expertise spans small molecules, peptides, protein–protein interactions and induced proximity therapeutics. His current work and writing focus on hybrid AI–physics methods, large language model-orchestrated R&D strategies, and scalable automation for evidence-based drug design.
ArticleBeyond templates: advancing protein–protein interaction structure prediction with AI
Dr Alan Nafiiev evaluates template-based, docking and template-free approaches to PPI prediction, highlighting how AI can enhance structural accuracy.